Work

Future directions of mammalian target of rapamycin (mTOR) inhibitor therapy in renal cell carcinoma

Year: 2011

Type: review

Source: Targeted Oncology

DOI: 10.1007/s11523-011-0172-y

Authors: Sumanta Kumar Pal, Robert A. Figlin

Institutions: City of Hope, Cedars-Sinai Medical Center, University of California, Los Angeles

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Award: City of Hope Clinical Oncology Career Research Development Program

OpenAlex ID: W2018774200

FWCI: 0.73

Cites: 54

Cited by: 14

Related to: 10